Trial Profile

Prospective Multicenter Observational Cohort Study of Comparative Effectiveness of Disease-modifying Treatments for Myasthenia Gravis

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 04 Feb 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Azathioprine (Primary) ; Mycophenolate mofetil (Primary)
Indications Myasthenia gravis
Focus Adverse reactions; Therapeutic Use
Acronyms PROMISE-MG

Most Recent Events

02 Feb 2021 Status changed from recruiting to completed.
11 Dec 2020 Planned End Date changed from 1 Nov 2020 to 31 Jan 2021.
11 Dec 2020 Planned primary completion date changed from 1 Nov 2020 to 31 Jan 2021.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com